Compass Capital Management’s Lamb Weston LW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-2,450
Closed -$219K 39
2022
Q4
$219K Buy
+2,450
New +$208K 0.02% 34
2022
Q1
Sell
-4,900
Closed -$311K 35
2021
Q4
$311K Hold
4,900
0.02% 34
2021
Q3
$301K Hold
4,900
0.02% 34
2021
Q2
$395K Hold
4,900
0.03% 34
2021
Q1
$380K Sell
4,900
-1,400
-22% -$110K 0.03% 34
2020
Q4
$496K Hold
6,300
0.04% 33
2020
Q3
$418K Sell
6,300
-600
-9% -$38.4K 0.04% 33
2020
Q2
$441K Hold
6,900
0.05% 34
2020
Q1
$394K Sell
6,900
-521
-7% -$42.8K 0.05% 33
2019
Q4
$638K Hold
7,421
0.07% 31
2019
Q3
$540K Hold
7,421
0.06% 32
2019
Q2
$470K Hold
7,421
0.06% 33
2019
Q1
$556K Sell
7,421
-732
-9% -$51.8K 0.07% 31
2018
Q4
$600K Hold
8,153
0.09% 31
2018
Q3
$543K Hold
8,153
0.07% 33
2018
Q2
$559K Hold
8,153
0.08% 33
2018
Q1
$475K Hold
8,153
0.07% 34
2017
Q4
$460K Hold
8,153
0.07% 36
2017
Q3
$382K Hold
8,153
0.06% 37
2017
Q2
$359K Hold
8,153
0.06% 37
2017
Q1
$343K Buy
8,153
+732
+10% +$28.9K 0.06% 38
2016
Q4
$281K Buy
+7,421
New +$253K 0.05% 39

Other funds holding LW

Compass Capital Management's LW Position: Q1 2023 in Review

Compass Capital Management sold out of Lamb Weston (LW) in Q1 2023, closing a stake of 2,450 shares — an estimated $219K sold.

Compass Capital Management first reported a position in LW in Q4 2016 and held it in 22 quarters. The position peaked at $638K in Q4 2019. 742 funds tracked by Wall St. Rank hold LW as of Q1 2023.

  • Compass Capital Management reported no remaining Lamb Weston position as of Q1 2023 after selling out during the quarter.
  • Compass Capital Management sold 2,450 Lamb Weston shares in Q1 2023, an estimated $219K.
  • Compass Capital Management first reported a position in Lamb Weston in Q4 2016 and held it in 22 quarters.
  • Compass Capital Management's Lamb Weston position peaked at $638K in Q4 2019.
  • 742 funds tracked by Wall St. Rank held Lamb Weston as of Q1 2023.

Based on Compass Capital Management's 13F filing for Q1 2023, filed 2 May 2023.